Page last updated: 2024-09-05

boswellic acid and fluvoxamine

boswellic acid has been researched along with fluvoxamine in 1 studies

Compound Research Comparison

Studies
(boswellic acid)
Trials
(boswellic acid)
Recent Studies (post-2010)
(boswellic acid)
Studies
(fluvoxamine)
Trials
(fluvoxamine)
Recent Studies (post-2010) (fluvoxamine)
227151472,051518434

Protein Interaction Comparison

ProteinTaxonomyboswellic acid (IC50)fluvoxamine (IC50)
DRattus norvegicus (Norway rat)0.54
D(3) dopamine receptorRattus norvegicus (Norway rat)0.54
D(1B) dopamine receptorRattus norvegicus (Norway rat)0.54
D(4) dopamine receptorRattus norvegicus (Norway rat)0.54
Sodium-dependent serotonin transporterHomo sapiens (human)0.0038
Sodium-dependent serotonin transporterRattus norvegicus (Norway rat)0.54
D(2) dopamine receptorRattus norvegicus (Norway rat)0.54
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)3.1
TransporterRattus norvegicus (Norway rat)0.54

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chhabra, S; Khan, Z; Mehan, S; Sethi, P1

Other Studies

1 other study(ies) available for boswellic acid and fluvoxamine

ArticleYear
Acetyl-11-keto-beta boswellic acid(AKBA) modulates CSTC-pathway by activating SIRT-1/Nrf2-HO-1 signalling in experimental rat model of obsessive-compulsive disorder: Evidenced by CSF, blood plasma and histopathological alterations.
    Neurotoxicology, 2023, Volume: 98

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Cerebral Cortex; Fluvoxamine; NF-E2-Related Factor 2; Obsessive-Compulsive Disorder; Plasma; Rats; Triterpenes

2023